Crestchem Limited concludes 34th AGM with remote e-voting

2 min read     Updated on 06 Aug 2026, 03:33 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Crestchem Limited held its 34th AGM on August 6, 2026, via video conference. Remote e-voting ran from August 3-5. The meeting addressed standard resolutions with no adverse audit comments noted. Final voting results await the Scrutinizer's report.

powered bylight_fuzz_icon
47556164

*this image is generated using AI for illustrative purposes only.

Crestchem Limited concluded its 34th Annual General Meeting (AGM) on August 6, 2026, utilizing video conferencing facilities in compliance with Securities and Exchange Board of India (SEBI) and Ministry of Corporate Affairs (MCA) guidelines. The meeting, chaired by Chairman and Managing Director Dipak Narendraprasad Patel, commenced at 12.15 PM IST and adjourned at 12.40 PM after a 15-minute window for final e-voting submissions.

The proceedings were conducted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholders participated through the Central Depository Services Limited (CDSL) platform. Remote e-voting commenced on August 3, 2026, at 9:00 AM and concluded on August 5, 2026, at 5:00 PM. Voting facilities were also available during the live meeting for those who had not cast their votes earlier.

Attendance and Quorum

A total of 42 members attended the meeting, satisfying the requisite quorum. All Board members were present except for Independent Director Priyanka M. Patel. Representatives from Statutory Auditors Samir N. Shah & Associates and Secretarial Auditor Mehul Raval & Associates also attended via video conference.

Entity Role Attendance Status
Dipak Narendraprasad Patel Chairman and Managing Director Present
Priyanka M. Patel Independent Director Absent
Samir N. Shah & Associates Statutory Auditors Present
Mehul Raval & Associates Secretarial Auditors Present

Proceedings and Disclosures

Dipak Narendraprasad Patel provided insights into the company’s performance over the past year and outlined future strategies. As there were no qualifications, observations, or adverse comments in the Auditor’s Report or Secretarial Audit Report that materially impacted the company’s functioning, these reports were not read out during the meeting. Resolutions were put to vote via the remote e-voting system, rendering the traditional proposal and seconding process unnecessary.

Shareholders registered as speakers raised queries, which were addressed to their satisfaction by management. Company Secretary and CFO Nitin S. Shah informed attendees that the voting results would be declared within statutory timelines upon receipt of the Scrutinizer’s report. Mr. Mehul Raval, Practicing Company Secretary, was appointed as the Scrutinizer for both remote and live e-voting processes.

What the Numbers Show

The AGM proceedings indicate strict adherence to regulatory compliance regarding virtual meetings and electronic voting protocols established during recent extraordinary circumstances. The absence of adverse comments from statutory or secretarial auditors suggests no material irregularities were detected in the financial statements or corporate governance practices for the period under review. The final voting outcomes remain pending the formal submission of the Scrutinizer’s report to the stock exchanges.

Historical Stock Returns for Crestchem

1 Day5 Days1 Month6 Months1 Year5 Years
+2.49%-4.20%+0.59%+41.94%-20.60%+82.50%

What specific growth strategies or capital allocation plans did Dipak Narendraprasad Patel outline for Crestchem's future operations?

How might the absence of Independent Director Priyanka M. Patel impact board oversight or future governance decisions?

Will the final voting results from the Scrutinizer's report reveal any significant shareholder dissent on key resolutions?

Crestchem fined ₹1,06,200 by BSE for late cash flow statement filing

2 min read     Updated on 04 Aug 2026, 06:54 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Crestchem Limited faces a ₹1,06,200 fine from BSE for late consolidated cash flow statement filing under Regulation 33 of SEBI Listing Regulations. The delay occurred due to the incorporation of subsidiary Oleo Biosciences Private Limited on March 31, 2026, resulting in no transaction data to consolidate. The company states the fine is financially immaterial and anticipates a potential waiver.

powered bylight_fuzz_icon
47395466

*this image is generated using AI for illustrative purposes only.

Crestchem Limited has been penalized ₹1,06,200 by the Bombay Stock Exchange Limited (BSE) for failing to submit its consolidated cash flow statement within the prescribed timeline. The exchange notified the company of the outstanding fine via email on August 4, 2026, at 10:29 AM, citing a violation of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory action highlights compliance risks associated with complex group structures and tight reporting deadlines.

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations. While the BSE communicated the monetary penalty, Crestchem Limited stated that it had not yet received the formal order or direction detailing the imposition of the fine as of the date of the communication. The company is required to pay the outstanding amount to regularize its standing with the exchange.

Particulars Details
Penalty Amount ₹1,06,200
Reason for Penalty Late submission of Consolidated Cash Flow Statement
Regulatory Violation Regulation 33 of SEBI Listing Regulations, 2015
Notification Date August 4, 2026

The delay in filing stemmed from the incorporation of the company’s subsidiary, Oleo Biosciences Private Limited, on March 31, 2026, which was the final day of the financial year. Because the subsidiary was established on the balance sheet date, it had no financial transactions to report as of that date. Consequently, there was no financial data requiring inclusion in the consolidated cash flow statement for the subsidiary, which contributed to the administrative delay in the consolidated filing process.

Financial Impact Assessment

Despite the regulatory breach, Crestchem Limited clarified that the fine will not have a material financial impact on its operations or balance sheet. The management expressed confidence that the exchange may consider a waiver for the penalty given the specific circumstances surrounding the subsidiary’s incorporation. The company emphasized that the absence of transactional data from the newly formed entity meant the omission did not reflect any underlying financial distress or reporting gap in substantive terms.

Nitin S Shah, Company Secretary, Compliance Officer & CFO of Crestchem Limited, signed the disclosure on August 4, 2026. The company has requested the BSE to take the explanation and the pending payment status on record. Investors should note that while the monetary value is immaterial, consistent adherence to listing obligations remains critical for maintaining regulatory goodwill.

Historical Stock Returns for Crestchem

1 Day5 Days1 Month6 Months1 Year5 Years
+2.49%-4.20%+0.59%+41.94%-20.60%+82.50%

Will the BSE grant a waiver for the penalty given Crestchem's explanation regarding the subsidiary's lack of transactional data?

How might this compliance lapse affect Crestchem Limited's regulatory standing or future listing obligations with SEBI and BSE?

What internal process improvements is Crestchem implementing to prevent similar administrative delays in future consolidated filings?

More News on Crestchem

1 Year Returns:-20.60%